How Genomics Are Revolutionizing The Cannabis Plant | Trade to Black TDR 2026-09-21 | How Genomics Are Revolutionizing The Cannabis Plant | Trade to Black
Hemp Leaders Meet in Washington Over Federal Ban | TTB Powered by Flowhub The Dales Report 2026-03-31 | The U.S. hemp industry is heading into its most critical moment since legalization in 2018.In this episode of Trade To Black, presented by Flowhub, host Shadd Dales and Anthony Varrell are joined by Thomas Winstanley of edibles.com following his recent trip to Washington, D.C., where hemp industry leaders met with lawmakers to address sweeping federal changes set to take effect in November 2026.At the center of the discussion is the newly passed federal hemp definition tied to the FY2026 Agriculture Appropriations Act, which effectively bans the majority of intoxicating hemp products by imposing strict total THC limits. The implications are significant—potentially impacting billions in retail sales, hundreds of thousands of jobs, and the future structure of cannabinoid-based consumer products in the U.S.This episode breaks down what’s actually in the legislation, why Congress moved in this direction following the 2018 Farm Bill loophole, and how states are already responding with their own restrictions and enforcement actions.Thomas provides insight into what was discussed behind closed doors in Washington, including efforts to delay implementation, protect full-spectrum CBD, and push for a regulated framework instead of prohibition.With the clock ticking toward November 2026, this is a pivotal moment that could reshape the entire hemp and cannabis landscape in the United States.00:00:00 Market bounce & MSO rumors00:03:39 Sponsor: Flowhub dispensary software00:04:06 Texas hemp ban goes live00:05:00 Hemp vs regulated cannabis flower debate00:08:39 CBD pilot, Charlotte’s Web & BAT stake00:12:34 SAM lawsuit vs CBD/THC Medicare pilot00:15:53 Rescheduling implications & SAM’s strategy00:17:30 Sponsor: Free nicotine pouches (FreePouch)00:17:48 Introducing Thomas Winstanley (edibles.com)00:20:00 DC lobbying week & competing hemp bills00:32:59 Hemp vs cannabis industry tension & policy paths00:51:09 McConnell’s role, hemp future & closing ban odds#CannabisIndustry #HempIndustry #CannabisNews #CBD #THC #CannabisPolicy #CannabisInvesting #HempBan #TradeToBlack #FlowhubWant to see more Cannabis Reform videos?🎬 youtu.be/od8OA6bv8i0🎬 youtu.be/-Op4xDYeAF0🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oMWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
White House Meetings Signal New CBD Rules | TDR Cannabis in 5 The Dales Report 2026-03-31 | White House meetings… FDA policy… and cannabis rescheduling all happening at the same time.In this episode of TDR Cannabis in 5, presented by Flowhub, Shadd Dales breaks down a developing story out of Washington that the entire cannabis industry is watching closely.According to new reporting, the Office of Management and Budget is hosting a series of high-level meetings with cannabis operators, hemp stakeholders, and industry groups. At the center of these discussions is a long-awaited FDA enforcement framework for CBD — an issue that has remained unresolved since the 2018 Farm Bill.While the focus appears to be on CBD, the broader implication is much bigger.These meetings are part of the formal rulemaking process, signaling that federal agencies are actively aligning on cannabis-related policy. And that matters — especially as the industry continues to wait on a final decision regarding cannabis rescheduling.For years, the lack of clear CBD regulation has allowed a massive, largely unregulated market to develop, including the rise of intoxicating hemp-derived THC products. Now, with growing pressure in Washington to address that issue, these meetings could shape future enforcement, product availability, and the competitive landscape across the sector.Individually, these are incremental steps.But together, they point toward a coordinated federal approach to cannabis regulation — something the market has been waiting for.00:00:00 - Intro 00:00:28 - White House Meetings 00:00:54 - CBD Policy Focus 00:01:20 - Policy Developments 00:01:46 - Ongoing Discussions 00:02:13 - CBD Enforcement Talks 00:02:39 - Regulatory Focus Shift 00:03:06 - Policy Implications 00:03:33 - White House Updates 00:03:59 - Industry Outlook 00:04:25 - Key Takeaways 00:05:19 - Closing Remarks #CannabisNews #CBD #CannabisPolicy #FDA #DOJ #CannabisRescheduling #HempIndustry #CannabisIndustry #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬 youtu.be/-Op4xDYeAF0🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Federal Pressure Mounts While States Hold the Line | TTB Presented by Flowhub The Dales Report 2026-03-30 | New York is marking five years of legalization with more than $3.3 billion in total cannabis sales, while pressure continues to build across the U.S.—from Congress demanding answers on rescheduling to new signals out of Indiana that the debate is far from settled.In this episode of Trade To Black presented by Flowhub, host Shadd Dales and Anthony Varrell walk through the latest developments shaping the cannabis industry.Segment one begins in New York as the state hits a major milestone, reinforcing its position as one of the largest regulated markets in the country. The focus then shifts to Washington, where Congressman Steve Cohen is pressing the DOJ for an update on cannabis rescheduling—now months removed from President Trump’s executive order directing the process forward.Segment two features Michael Bronstein, President of the American Trade Association for Cannabis and Hemp (ATACH), providing policy insight on what’s unfolding at both the federal and state level.That includes Indiana, where Governor Mike Braun is now openly acknowledging that legalization pressure is rising. He points to widespread use, surrounding legal states, and shifting views among law enforcement—even as legislative leadership remains opposed for now.With federal rescheduling still in motion and state-level dynamics continuing to evolve, the broader direction is becoming clearer.The takeaway—pressure is building, and the tone is starting to change.00:00:00 Intro: Federal Cannabis & CBD Outlook00:02:00 Cannabis Stocks & ETFs (MSOS, CNBS, YOLO)00:04:20 Texas Hemp Ban & New York Market Surge00:08:25 Rescheduling & CBD Framework (with Michael Bronstein)00:19:30 Hemp Beverages, Intoxicating Hemp & DC Politics00:30:00 State Pressure (Indiana) & 2028 Election Scenarios00:44:00 Biden vs Trump on Cannabis Reform + Prediction00:50:10 Outro & TDR+ Plug#CannabisNews #CannabisReform #MarijuanaPolicy #CannabisIndustry #CannabisLegalization #USCannabis #NewYorkCannabis #IndianaCannabis #CannabisStocks #TradeToBlackWant to see last week's recap?🎬 youtu.be/UNaEwqXl5kgWant to see more Cannabis Reform videos?🎬 youtu.be/-Op4xDYeAF0🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Cannabis ETFs Tell the Real Story | TDR Cannabis in 5 The Dales Report 2026-03-30 | In a market where everything feels red… the ETF landscape is telling a clearer story.In today’s episode of TDR Cannabis in 5, presented by Flowhub, we step back from individual stocks and look at how cannabis ETFs have actually performed over the same timeframe — from late August through today.And the reality is pretty straightforward.AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS) is down over 51 percent. ETFMG Alternative Harvest ETF (NYSEARCA: MJ) is down nearly 48 percent. Amplify Seymour Cannabis ETF (NYSEARCA: CNBS) is down more than 63 percent. Even broader exposure vehicles like Cambria Cannabis ETF (BATS: TOKE) are shutting down altogether.But within that same environment, one ETF has held up better than the rest.AdvisorShares Pure Cannabis ETF (NYSEARCA: YOLO).Not because it’s been strong — but because it’s been less weak.That difference comes down to structure. YOLO isn’t fully tied to U.S. multi-state operators. Instead, it includes names like Village Farms International (NASDAQ: VFF), High Tide Inc. (NASDAQ: HITI) (TSXV: HITI), Cronos Group (NASDAQ: CRON) (TSX: CRON), Charlotte’s Web Holdings (TSX: CWEB) (OTCQX: CWBHF), and Organigram Holdings (NASDAQ: OGI) (TSX: OGI).And in this kind of market, diversification has mattered.This isn’t a strong market — but it’s a selective one. And right now, that distinction is starting to show.00:00:00 — Cannabis Market Outlook00:00:27 — ETF Sector Overview00:00:55 — ETF Closures Rise00:01:23 — Sector Performance Decline00:01:50 — Liquidity Pressures Build00:02:18 — YOLO ETF Positioning00:02:46 — Diversification Strategy Edge00:03:14 — Risk Management Approach00:03:42 — Weekly Performance Review00:04:09 — Market Rotation Signals#CannabisStocks #CannabisETF #MSOS #YOLOETF #CannabisInvesting #CannabisMarket #CannabisNews #TDR #StockMarket #ETFInvestingWant to see last week's recap?🎬 youtu.be/UNaEwqXl5kgWant to see more Cannabis Reform videos?🎬 youtu.be/-Op4xDYeAF0🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Cannabis Stocks React to Policy Uncertainty | TTB Weekly Recap The Dales Report 2026-03-29 | Four months later… and still no timeline.In this week’s Trade To Black Weekly Recap presented by Frepouch.com, we break down growing pressure in Washington as Congressman Steve Cohen calls on the Department of Justice for an update on cannabis rescheduling. Despite President Donald Trump’s executive order back in December, there’s still no clarity from the DOJ or DEA on when — or if — Schedule III becomes reality.Beyond Washington, this week delivered a wave of meaningful business developments across the cannabis sector.Companies like Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) and Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF) posted strong earnings, highlighting continued execution in the Canadian market. Meanwhile, Glass House Brands (Cboe CA: GLAS.A.U) (OTCQX: GLASF) (OTCQX: GHBWF) is positioning for a major production ramp in 2026.On the expansion front, Curaleaf Holdings (TSX: CURA) (OTCQX: CURLF) continues to scale in Florida, while Vireo Growth (CSE: VREO) (OTCQX: VREOF) closed a significant acquisition across Colorado and New Mexico, reinforcing ongoing consolidation trends.On the other side of the spectrum, The Cannabist Company (Cboe CA: CBST) (OTCQB: CBSTF) is entering a restructuring phase, underscoring the balance sheet challenges still facing parts of the industry.Additional updates from LEEF Brands (CSE: LEEF) (OTCQB: LEEEF), Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF), and Avicanna (TSX: AVCN) (OTCQX: AVCNF) round out a week that reflects both progress and pressure across the cannabis sector.00:00:00 Intro00:00:49 Rep. Cohen's Letter to DOJ & DEA00:03:14 Georgia's Medical Cannabis Expansion00:03:44 Ohio Adult-Use Finalized00:04:10 Rubicon Organics FY25 Milestone00:05:15 Auxly FY25 Earnings00:06:22 Glass House FY25 Earnings00:07:29 Curaleaf Expands in FL (Cape Coral)00:08:09 Vireo Closes Schwazze Deal 00:08:53 The Cannabist Company Enters CCAA00:09:49 LEEF Brands FY25 Earnings00:10:06 Jushi Reaches Hemp Settlement00:10:22 Avicanna Signals Global Cannabis Supply Shift00:11:00 Wrap-up #CannabisIndustry #CannabisStocks #CannabisNews #DOJ #CannabisRescheduling #MSOS #CannabisInvesting #TDR #CannabisEarnings #CannabisMarketWant to see more Cannabis Reform videos?🎬 youtu.be/-Op4xDYeAF0🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Congressman Pressures DOJ on Cannabis Rescheduling | TDR Cannabis in 5 The Dales Report 2026-03-28 | Three months later… and still no update.In today’s episode of TDR Cannabis in 5, presented by Flowhub, we break down the growing pressure on the Department of Justice as delays continue around federal cannabis rescheduling.Back on December 18th, President Donald Trump signed an executive order directing the DOJ to move cannabis from Schedule I to Schedule III. At the time, markets reacted quickly — with expectations that this would move fast.But here we are now… and nothing has changed.According to new reporting from Marijuana Moment, Congressman Steve Cohen is now demanding answers from Attorney General Pam Bondi and the DEA, asking a simple question: where is the timeline?This isn’t just about politics — it’s about execution.Because while the executive order created momentum, the actual rescheduling process still requires a formal rulemaking process. And right now, that process appears stalled.We also get into a key issue that’s flying under the radar — the DOJ missing a federal deadline tied to cannabis research reform, which only adds more pressure to an already delayed process.For investors, this matters.The market priced in speed… and now it’s dealing with uncertainty.Until a final rule is published, cannabis remains a Schedule I substance — and that means no real change yet.00:00:00 — Intro00:00:30 — Market Uncertainty Pressures00:01:00 — Rescheduling Strategic Importance00:01:25 — Federal Policy Developments00:01:50 — DEA Review Process00:02:15 — Regulatory Risks Ahead00:02:40 — Investor Sentiment Shifts00:03:05 — Sector Performance Divergence00:03:30 — Rescheduling Timeline Outlook00:03:55 — Key Market Catalysts00:04:20 — Bull Bear Outlook00:04:50 — Key Takeaways Ahead#CannabisIndustry #CannabisRescheduling #DOJ #DEA #CannabisStocks #CannabisNews #FederalReform #Schedule3 #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬 youtu.be/zvEVNM2gyKI🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
CLIMB Act Could Change Cannabis Forever | TDR Cannabis in 5 The Dales Report 2026-03-27 | A federal bill that’s getting very little attention right now… but could completely change the financial structure of the U.S. cannabis industry.Today we’re breaking down the CLIMB Act — and why this goes way beyond banking. This isn’t just about access to financial services… it’s about unlocking capital, institutional investment, and potentially allowing U.S. cannabis companies to list on major exchanges like the NYSE and NASDAQ.TDR Cannabis in 5 presented by FRE Nicotine Pouches, hosted by Shadd Dales, takes a closer look at what the CLIMB Act actually does, why it matters for MSOs, and how it compares to SAFE Banking. From safe harbor protections to SBA loan access and investor protections, this bill could level the playing field between U.S. and Canadian operators.The reality is simple — without capital, the industry can’t scale. And while the market continues to focus on rescheduling, legislation like this could have a far more direct impact on valuations, liquidity, and long-term growth.If this moves forward, it’s not just incremental change — it’s structural.00:00:00 — Intro00:00:30 — The CLIMB Act: A Clear Explanation00:00:50 — Why the CLIMB Act Matters00:01:10 — Federal vs. State Dynamics in Cannabis Policy00:01:30 — Capital Access Challenge in Cannabis00:01:55 — How the CLIMB Act Addresses Financing Gaps00:02:20 — Key Implications for Cannabis Operators00:02:45 — Potential Impact on Industry Expansion00:03:10 — Legislative Risks and Uncertainty00:03:40 — What Passage Could Mean for the Market00:04:20 — Investor Takeaways and What to Monitor#CannabisIndustry #CLIMBAct #CannabisStocks #MSOS #CannabisInvesting #SAFEbanking #CannabisNews #NYSE #NASDAQ #CannabisReschedulingWant to see more Cannabis Reform videos?🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
High Tide Reports Record Earnings + Missouri Hemp Crackdown | TTB Presented by Flowhub The Dales Report 2026-03-26 | In this episode of Trade To Black, presented by Flowhub, hosts Shadd Dales and Anthony Varrell cover three key stories across earnings, hemp policy, and medical cannabis reform.We start with Raj Grover, CEO of High Tide (NASDAQ:HITI), following a strong quarterly report. The company posted record revenue of $178.3 million, improved margins, and continued free cash flow generation. We discuss what’s driving performance, including retail market share gains, Cabana Club growth to over 2.5 million members, and progress internationally in Germany.Then Adam Stettner returns in segment #2 to break down what’s actually happening in Missouri. Despite headlines, there is no official hemp ban. A House bill passed but stalled in the Senate, while regulators continue enforcement actions targeting intoxicating hemp products. The conversation focuses on what operators need to understand right now.We also look at changes in Georgia, where lawmakers are expanding the medical cannabis program. New rules remove THC caps, allow vaporization, and broaden qualifying conditions — a meaningful shift for patient access and market growth.This episode focuses on what’s real, what’s changing, and what matters for investors and operators.00:00:00 Show open: Markets, Trump comment & podcast setup00:00:40 Introducing High Tide & sponsor Flowhub00:02:03 High Tide CEO on record earnings and consistency00:05:00 Germany expansion: Remexian acquisition & market share gains00:09:10 Big opportunity in UK medical cannabis market00:11:06 Global strategy: Canadian procurement powering Europe growth00:17:34 Cabana Club & Elite: Membership model and sticky customers00:20:00 U.S. CBD strategy, NCCC & CMS pilot program00:22:48 2026 outlook for High Tide and industry headwinds00:25:05 Segment 2: Missouri hemp crackdown and state-by-state trends00:33:35 Georgia, North Carolina, South Carolina: the next big corridor00:47:01 Intoxicating hemp drinks, THC beverages & future of distribution#CannabisStocks #HighTide #HempPolicy #GeorgiaCannabis #MissouriHemp #CannabisInvesting #CannabisNews #RajGrover #AdamStettner #CannabisIndustry #CannabisNewsWant to see more Cannabis Reform videos?🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Avicanna Signals Global Cannabis Supply Shift | Trade to Black The Dales Report 2026-03-26 | This is one of those stories that might not grab headlines right away… but probably should.In today’s episode, we’re breaking down a major milestone from Avicanna (TSX: AVCN), as their subsidiary SMGH completes its first commercial export of organic, CBG-dominant cannabis flower to Australia — one of the most tightly regulated medical markets in the world.On the surface, it’s an export story.But when you step back… it’s really about something bigger.For years, the industry has talked about whether cannabis can be grown more efficiently outside of North America — lower cost, better climate, scalable production. A lot of companies tried. Most didn’t make it.Now we’re starting to see what execution actually looks like.In this conversation, we get into:* Why this export matters more than people think* How Colombia is positioning itself in the global supply chain* The role of organic cultivation and cost advantages* And what this could mean for international medical markets moving forwardIf you’re looking at where cannabis is heading over the next 3–5 years — especially from a global and supply chain perspective — this is one to pay attention to.00:00:00 Major Cannabis Export Breakthrough00:00:25 Why This Announcement Matters00:01:02 The Cost Advantage in Cannabis00:01:43 Why Most Cannabis Companies Failed00:02:06 CEO Breaks Down the Milestone00:02:49 Veteran Grower Shares Insights00:03:44 Inside the Australia Export Deal00:04:36 SMG’s Business Model Explained00:05:58 First Export Marks Expansion Start00:07:05 Large-Scale Production Capacity00:08:33 Why CBG Was Chosen First00:10:09 THC Export Challenges Explained00:11:31 Limits of Indoor Cultivation00:16:55 Outdoor vs Indoor Cultivation00:20:37 Colombia’s Competitive Advantage00:30:12 The Future of Cannabis Supply#Avicanna #CannabisIndustry #MedicalCannabis #CannabisExports #CannabisInvesting #GlobalCannabis #CannabisStocks #CBG #CannabisNews #CannabisMarketWant to see more Cannabis Reform videos?🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Top Cannabis Physician Explains CBD Pilot | TTB Presented by Flowhub The Dales Report 2026-03-25 | In this episode of Trade To Black, presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down the new Medicare CBD pilot program — and why it could end up being one of the more important federal developments we’ve seen in years.For the first time, the U.S. government is testing a structured model where Medicare patients can receive a $500 annual benefit card to purchase qualifying hemp-derived CBD products. This is tied directly to the 2027 Medicare rule — so this isn’t theoretical, it’s a real pilot that’s been put in motion.To help make sense of it, Dr. Leigh Vinocur joins the show — one of the leading cannabis physicians in the country and a member of the National Cannabis Care Council (NCCC). This isn’t just a surface-level conversation — we get into how this actually works for patients, what kind of physician oversight is involved, and what CMS is ultimately trying to measure through this program.But the bigger question is this:Is this just a contained pilot… or an early step toward cannabinoids being integrated into the U.S. healthcare system?Because if this expands beyond 2027 — the implications for companies, investors, and policy are significant.00:00:00 CBD Pilot Program Explained in 30 Seconds00:02:03 Why the CBD Pilot Could Change Senior Healthcare00:03:32 “Hemp vs. Cannabis”: Are They Actually Different?00:04:30 Can CBD Help Replace Opioids for Chronic Pain?00:08:45 Is the CBD Pilot a Stepping Stone to Full Cannabis Reform?00:10:00 It’s 2026: Why Is Cannabis STILL Schedule I?00:17:57 How the $500 CBD Card for Seniors Will Really Work00:23:14 Could Peptides & Compounding Pharmacies Be the Blueprint for Cannabis?00:28:01 The “Gateway Drug” Myth vs. Real Patient Data00:31:28 Good Hemp vs. Bad Actors: What Went Wrong with Delta-8 & THCA?00:35:00 Did Congress Go Too Far with the Upcoming Hemp Ban?00:43:10 Why the Hemp Ban Might Actually Create Stronger Cannabis Companies#CannabisIndustry #CBD #Medicare #CannabisPolicy #Hemp #CannabisInvesting #HealthcareInnovation #CannabisStocks #Regulation #TDRWant to see more Cannabis Reform videos?🎬 youtu.be/sC8XVhcTwyk🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Hemp THC Drinks Shift Toward Federal Regulation | TDR Cannabis in 5 The Dales Report 2026-03-25 | A shift is starting to take shape in Washington around hemp-derived THC beverages — and it’s coming from an unexpected place.New reporting from Marijuana Moment highlights how a major alcohol industry group is now pushing lawmakers to regulate THC drinks instead of banning them outright. That change in tone matters, especially as pressure continues to build around intoxicating hemp products and the future of the 2018 Farm Bill.On this episode of TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down what’s actually happening, why the alcohol industry is stepping in now, and what this could mean for cannabis, hemp, and broader THC regulation in the United States.This isn’t just about beverages — it’s about who controls the category moving forward. As states tighten rules and federal conversations evolve, the focus is shifting away from whether these products should exist, and toward how they should be regulated.For investors and operators, that distinction matters.Because once a category moves from gray market to regulated framework, the entire competitive landscape changes.00:00:00 Intro00:00:24 Alcohol Industry Enters THC00:00:46 Push to Regulate Instead of Ban00:00:52 Federal Ban Timeline Explained00:01:25 THC Drinks Market Boom00:01:47 Hemp Loophole & Legal Background00:02:02 Alcohol Industry Strategy Shift00:02:20 Consumers Moving Away from Alcohol00:02:49 Regulation vs Ban Debate00:03:13 Risks & Regulatory Confusion00:03:57 What This Signals for Investors00:04:15 Bigger Industry Trend00:04:39 End of “Wild West” Phase00:04:42 Final Thoughts: Control of the Market#CannabisNews #HempTHC #THCDrinks #CannabisPolicy #FarmBill #CBD #CannabisIndustry #THCRegulation #CannabisInvesting #BigAlcoholWant to see more Cannabis Reform videos?🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Rubicon Organics & SNDL Earnings Breakdown Analysis | TTB Powered by Flowhub The Dales Report 2026-03-24 | On the latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down a busy stretch of cannabis earnings with two very different operators.In segment one, Margaret Brodie, CEO of Rubicon Organics Inc. (TSXV: ROMJ, OTCQX: ROMJF), checks in to walk through their latest numbers. The company delivered record full-year revenue of $59.5 million, up 22% year-over-year, along with $5 million in adjusted EBITDA. The conversation focuses on what really changed this year — the Cascadia facility now coming online, more capacity, and how that shifts the business from being supply-constrained to actually having room to grow. There’s also a deeper look at premium positioning, genetics, and where margins could go in 2026.Then in segment two, Zach George, CEO of SNDL Inc. (NASDAQ: SNDL, CSE: SNDL), joins the show following a strong year financially. SNDL reported $946.4 million in revenue, $49.9 million in adjusted EBITDA, and $58.1 million in operating cash flow — while sitting on over $252 million in cash and no debt. The conversation gets into how they’ve reshaped the business, where capital is being deployed, and how they’re thinking about the next phase of growth.Two companies. Two different strategies. Same market.00:00:00 Intro, Market Recap & Cannabist Bankruptcy00:09:26 Big Alcohol vs Hemp THC Drinks00:11:56 Rubicon: Record Earnings & Cascadia Deal00:17:39 Premium Strategy: 1964 Brand, Pre-Rolls & Vapes00:22:12 Canada Outlook: Margins, Excise & Consolidation00:37:47 SNDL: 2025 Results & Cannabis/Liquor Mix00:45:39 Retail Saturation & Canadian M&A Setup00:49:24 SNDL’s Capital Allocation & U.S. Assets00:55:00 Bear Market, Cheap Valuations & M&A Wave01:00:19 CBD Medicare Pilot Program & $500 Stipend Explained#CannabisStocks #CannabisEarnings #TradeToBlack #RubiconOrganics #SNDL #CannabisInvesting #CannabisIndustry #MSO #CannabisNews #ShaddDalesWant to see more Cannabis Reform videos?🎬 youtu.be/l7uQmSJa-oM🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxgWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Medicare CBD Program Raises Questions In Washington | TDR Cannabis in 5 The Dales Report 2026-03-24 | On the latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down newly released details around a federal CBD pilot program tied to Medicare patients — and why the timing is raising questions across the cannabis industry.According to reporting from Marijuana Moment, the program will allow select Medicare patients to receive up to $500 annually in hemp-derived cannabinoid products, including orally administered formats like tinctures, capsules, and edibles. These products can include limited amounts of THC and must comply with state laws.What stands out is how the program is structured. Rather than direct federal reimbursement, it’s being implemented through ACO-style healthcare groups that are incentivized to reduce overall patient costs. That means cannabinoid treatments are only being used when providers believe they can improve outcomes and reduce healthcare spending.At the same time, cannabis remains federally classified as a Schedule I substance.This episode looks at that disconnect — and what it could signal. Whether this is an early-stage workaround or part of a broader shift in federal policy, it represents one of the first real examples of cannabinoids being introduced into a federally connected healthcare system.For investors and operators, the takeaway is straightforward: this is still a limited pilot, but it may point to where things are heading next.00:00:00 - Intro00:00:46 - CBD Pilot Program00:01:32 - Medicare Connection00:02:19 - Schedule I Conflict00:03:05 - Timeline Update00:03:50 - Federal Healthcare Impact00:04:36 - Policy Implications00:05:21 - Closing Remarks#CannabisNews #CBD #Medicare #CannabisPolicy #CannabisReform #CannabisStocks #Healthcare #CannabisIndustry #Flowhub #CannabisReschedulingWant to see more Cannabis Reform videos?🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxg🎬 youtu.be/Ty8MKF1z_GoWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
CBD Program Details Released as Hemp Rules Tighten | TTB Powered by Flowhub The Dales Report 2026-03-23 | In our latest Trade To Black podcast presented by Flowhub, we break down a story that’s starting to raise more questions than answers across the cannabis and hemp industries.In our first segment, we get into a federal CBD pilot program that’s set to begin in April. Based on the latest details, it could allow cannabinoid-based therapies — including products with small amounts of THC — inside a healthcare setting. At the same time, a separate report from the New York Post this weekend pointed to continued delays around cannabis rescheduling at the federal level.So you’ve got one part of the government moving slowly on policy… and another part quietly moving forward with real-world use.Then you layer in what’s happening at the state level.Some states are tightening restrictions on hemp-derived THC products, while others are choosing to regulate and allow them with limits. All of this is happening ahead of a federal ban on hemp-derived THC expected to take effect in November 2026.In Segment 2, we’re joined by Michael Bronstein, President of ATACH, to walk through what’s actually happening here. We get into the growing divide between federal and state policy, how operators should be thinking about this shift, and whether hemp companies are now being pushed into a state-by-state model that looks a lot more like cannabis.This one is less about headlines — and more about understanding where things are actually going.00:00:00 Intro: CBD Pilot Framework & Market Catch‑Up00:03:04 Sponsor: Flowhub & Welcoming Michael Bronstein00:05:46 What Is the Federal CBD Pilot Program? (Key Details)00:09:56 $500 Benefit, ACOs & What Success Could Mean (Medicare/2027)00:18:47 State Focus: Ohio vs South Carolina & Hemp Regulation00:24:07 Do We Still Need Unregulated Hemp in Adult‑Use States?00:30:23 “Synthetics” vs “Exotics”: Clarifying Delta‑9, HHC, THCP, etc.00:35:29 Will the Hemp Ban Be Delayed? What Congress Is Really Signaling00:43:29 Hemp vs Cannabis: Free Market, Parity & Who Built the Industry00:54:21 Georgia’s Big Move: Vapes & THC Caps Lifted00:58:39 What’s Next: Upcoming Guests & Closing#cannabis #hemp #cannabisnews #cannabisindustry #cbd #thc #cannabisstocks #msos #federalpolicy #investingWant to see last week's recap?🎬 youtu.be/TA0YoeVeul0Want to see more Cannabis Reform videos?🎬 youtu.be/YW38xOwj2c8🎬 youtu.be/10FeLRPbjxg🎬 youtu.be/Ty8MKF1z_GoWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Does Cannabis Rescheduling Actually Unlock Banking Access | TDR Cannabis in 5 The Dales Report 2026-03-23 | On the latest TDR Cannabis in Five powered by Flowhub, host Shadd Dales breaks down one of the biggest questions in the cannabis industry right now — if cannabis is rescheduled to Schedule III, does that actually unlock banking?For years, the assumption has been simple: rescheduling leads to institutional capital, broader banking access, and a more normalized financial system for cannabis companies.But a recent legal analysis from the National Law Review suggests the reality may be more measured.While rescheduling would remove the burden of IRS 280E, improving margins and cash flow for operators, it does not automatically change how banks interact with the industry. Financial institutions would still be required to follow existing regulations under the Bank Secrecy Act and current FinCEN guidance.That means compliance requirements, monitoring, and reporting obligations would remain in place — at least in the near term.The episode looks at what actually changes, what doesn’t, and why expectations around banking may need to be adjusted.It also highlights where progress could come from next, including updated regulatory guidance or federal legislation like the SAFE or SAFER Banking Act.For investors and operators, the takeaway is straightforward: rescheduling would be meaningful, but it would likely represent a step forward — not a complete shift — when it comes to capital access and banking.00:00 — Show Intro & Setup00:08 — Big Cannabis Question00:20 — Rescheduling Hype Explained00:38 — Does Banking Actually Change?01:05 — Reality vs Expectations01:40 — Why Banks Still Avoid Cannabis02:15 — Regulatory Barriers Breakdown02:55 — Financial System Limitations03:30 — What Needs to Happen Next04:05 — Industry Outlook & Risks04:35 — Final Takeaways#CannabisNews #CannabisBanking #CannabisPolicy #CannabisReform #CannabisStocks #ScheduleIII #SAFEbanking #CannabisIndustry #Flowhub #ShaddDalesWant to see last week's recap?🎬 youtu.be/TA0YoeVeul0Want to see more Cannabis Reform videos?🎬 youtu.be/10FeLRPbjxg🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNAWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
The Rise of Cannabis Medicine The Dales Report 2026-03-23 | #Cannabis #MedicalCannabis #WeedIndustry #Cannabinoids #CBD #CBG #THC #HealthTech #Biotech #Wellness #Pharma #Investing #StockMarket #Shorts #YouTubeShorts #Trending #Viral
FDA Moves Closer To CBD Market Regulation | TTB Weekly Recap The Dales Report 2026-03-22 | On the latest TDR Weekly Recap presented by FRE Nicotine Pouches, host Shadd Dales breaks down another busy week across the cannabis industry — from federal policy and new data to earnings and company developments.While there’s still no official update on U.S. cannabis rescheduling, the broader conversation continues to shift. New data highlighted by the DEA shows long-term declines in youth cannabis use, challenging one of the core arguments that has supported prohibition for decades.At the same time, the FDA has submitted a CBD compliance framework for White House review, signaling that federal oversight of the CBD market may finally be taking shape.On the business side, several companies made headlines this week.High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) reported record revenue of $178 million and continued growth in its Cabana Club membership, now exceeding 2.5 million members.Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) announced a Phase I clinical trial focused on THC capsules for anxiety, marking another step toward pharmaceutical-style cannabis development.Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) completed its acquisition of MTL Cannabis, strengthening its medical platform.Cannabix Technologies Inc. (CSE: BLO) (OTCQB: BLOZF) recorded its first commercial sale of a marijuana breathalyzer device.Internationally, Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) continues expanding its medical cannabis footprint in Australia.From policy shifts to company execution, the cannabis industry continues to move forward — even as federal reform remains pending.00:00:00 Intro00:00:26 DEA Study on Youth Cannabis Usage00:02:27 FDA on CBD Regulation00:04:23 Alcohol & Tobacco vs Cannabis Study00:05:06 Virginia Adult-Use Update00:06:06 High Tide Earnings Update00:06:51 Avicanna's Phase I THC Trial00:07:24 Canopy Completed MTL Cannabis Acquisition00:07:38 Cannabix Records First Breathalyzer Sale00:08:09 Tilray Expands in Australia00:08:22 Cannabis in Brain Health00:09:07 Wrap-up#CannabisNews #CannabisIndustry #CannabisPolicy #CannabisStocks #CannabisReform #CBD #THC #CannabisResearch #TDRWeeklyRecap #CannabisReschedulingWant to see more Cannabis Reform videos?🎬 youtu.be/10FeLRPbjxg🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNAWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Texas Hemp Ban Creates Winners And Losers | TDR Cannabis in 5 The Dales Report 2026-03-21 | On the latest TDR Cannabis in Five powered by FRE Nicotine Pouches, host Shadd Dales takes the Texas hemp story one step further — breaking down what happens next after the state’s decision to remove smokable hemp THC products from the market.The ban itself is now clear. But the bigger question is what it actually means across the supply chain.This episode looks at who’s impacted most — and it’s not just unlicensed smoke shops.Licensed hemp retailers are losing their highest-demand products overnight, including THCA flower and pre-rolls, while hemp farmers — both in Texas and across the United States — are now dealing with a sudden drop in demand tied directly to smokable products.A large portion of that supply had been coming from states like Oregon, California, and Colorado, making this more than just a Texas story.At the same time, the shift creates a new dynamic.Edibles and THC beverages remain legal, meaning the market isn’t disappearing — it’s moving.The discussion also looks at what this signals from a regulatory standpoint, as Texas draws a clearer line between unregulated hemp products and what would typically fall under a licensed cannabis system.And from a broader industry perspective, the move could have implications for how other states — and potentially federal regulators — approach the intoxicating hemp category moving forward.00:00:00 Intro00:00:18 Texas Hemp Controversy00:00:42 Retail Crackdown Debate00:01:08 Regulation vs Reality00:01:32 Lawmakers vs Industry00:01:58 THC Loophole Explained00:02:24 Enforcement Challenges Rise00:02:52 Economic Impact Concerns00:03:20 Public Safety Arguments00:03:48 Federal vs State Conflict00:04:18 Future of Hemp Market00:04:50 What Happens Next00:05:20 Final Thoughts & Wrap#CannabisNews #HempIndustry #TexasHemp #THCA #CannabisPolicy #CannabisRegulation #CannabisIndustry #CannabisInFive #FREpouch #ShaddDalesWant to see more Cannabis Reform videos?🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLkWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
HEMP CHAOS: THC, CBD, & Power Plays The Dales Report 2026-03-20 | #CannabisNews #FarmBill #HempIndustry #CannabisPolicy #THCBan #CannabisRegulation #CannabisReform #Delta8 #CannabisIndustry
Capital Discipline: Navigating VAs Adult-Use Shift w/out Over-Leveraging | TTB Presented by Flowhub The Dales Report 2026-03-19 | In this episode of the Trade to Black presented by Flowhub, host Anthony Varrell (@V_arrell) interviews Adam Stettner, CEO of FundCanna, the leading cannabis financing platform offering fast, flexible loans and working capital to operators nationwide. With Virginia's adult-use cannabis sales set to launch January 1, 2027—following recent legislative approval and expected Gov. Spanberger signature—the Commonwealth is on the cusp of a major transition from possession-only to full retail legalization. Adam and Anthony unpack critical lessons from past state rollouts (Illinois, Massachusetts, Michigan, California) to help Virginia businesses avoid common—and expensive—mistakes.The discussion centers on why execution risk in the first 12–36 months often outweighs the legalization itself. Operators who chase adult-use as an instant revenue surge frequently over-allocate capital and scale too aggressively, facing prolonged cash burn and delayed inflows. Successful transitions have been led by disciplined players who prioritize risk management, margin protection, supply chain stability, and liquidity over rapid top-line growth. They highlight regulatory realities: most markets endure longer-than-expected timelines, licensing delays, zoning conflicts, phased launches, and uneven competition. License imbalances can distort the market—over-issuing retail relative to cultivation risks shortages, while excess cultivation commonly triggers price compression and inventory overhang.Adam explains predictable supply-demand swings: early novelty demand masks weaknesses before flipping to oversupply, punishing hype-driven scaling. Inefficient dynamics—opaque wholesale pricing, bottlenecks, and capital tied in inventory/receivables—complicate cash flow. Capital discipline shines here: flexible, short-duration funding enables adaptation without over-leveraging, while many medical operators underestimate adult-use working capital needs. The transition ultimately tests management skill and balance sheet strength as much as it offers growth.Essential listening for Virginia cultivators, retailers, investors, and anyone tracking emerging cannabis markets.00:00:00 Intro Uplisting Bill, Cartel Crackdowns & Teen Use Data00:03:41 CMS Pilot Rumors, Delta-8/10, THCA & Looming Hemp Ban00:05:34 Why Cannabis Stocks Don’t Move on Headlines Anymore00:06:58 Today’s Focus: Capital Discipline in Cannabis (Guest: Adam Stettner)00:14:27 Virginia’s Adult-Use Flip: Opportunity, Risks & State Comparisons00:19:45 Capital Discipline 101: Delays, Overbuilding & Over-Leverage00:26:37 Hemp vs Cannabis: November Ban Risk & How Lenders See It00:34:21 Policy Done Right: Texas, Taxes, Parity & Fixing Hemp/Cannabis Together00:43:04 Interstate Commerce: Who Wins, Who Loses & Market Normalization00:51:40 Future of Hemp Beverages, Big Alcohol & Cannabis vs Alcohol Long-Term#TradeToBlack #CannabisStocks #CannabisNews #CannabisInvesting #ScheduleIII #Rescheduling #MSO #capitalmarkets Want to see more Cannabis Reform videos?🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLkWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
The Cannabis Capital Markets Are Ready To Catch Fire | TTB Powered by Flowhub The Dales Report 2026-03-18 | Trade to Black presented by Flowhub hosted by Anthony Varrell is back with another high-level conversation on the biggest issues shaping the cannabis industry, cannabis capital markets, rescheduling, and cannabis M&A.In today’s episode, Anthony is joined by Sammy Armenia from C21 Investments to break down the current state of cannabis capital market activity, what investors and operators are seeing across the sector, and where capital is actually flowing in today’s market. From debt and equity financing to investor sentiment and public market dynamics, this discussion takes a close look at how cannabis companies are navigating one of the industry’s most important turning points.The conversation also dives into the real viability and impact of cannabis rescheduling, including what a move to Schedule III could mean for operators, tax treatment, valuations, access to capital, and the broader investment landscape. Anthony and Sammy also discuss the road ahead for potential mega-merger M&A, industry consolidation, and whether the cannabis sector is finally approaching the scale needed for transformational deals.If you follow cannabis stocks, cannabis investing, rescheduling news, Schedule III, cannabis mergers and acquisitions, MSOs, or cannabis capital markets, this is an episode you do not want to miss.00:00 Intro: Market recap & teen cannabis use narrative01:31 Mega mergers & MSO consolidation thesis03:42 Guest intro: Sammy from C21 & personal catch‑up06:49 C21 & Nevada: earnings, competition & consolidation09:36 Price compression, $20 eighths & consumer economics12:09 Schedule III, stigma, hemp/illicit markets & growth drivers14:11 280E, UTP overhang & true profitability of MSOs18:09 Cost of capital, refinancing & valuation re‑rating potential23:23 What big MSO mergers could look like (Trulieve, Cresco, Curaleaf, GTI, etc.)25:42 State catalysts: VA, PA, TX, FL & the Southeast expansion story31:02 Hemp loophole, Nevada’s $300M hit & policy enforcement36:03 Market structure: ETFs, algos, naked short fears & retail exhaustion50:26 C21 growth strategy & disciplined capital allocation55:28 Event‑driven history of cannabis stocks & long‑term investment thesis58:50 Sponsor: Flowhub & closing remarks#TradeToBlack #C21Investments #CannabisStocks #CannabisNews #CannabisInvesting #ScheduleIII #Rescheduling #CannabisMergers #CannabisMAndA #MSO #CapitalMarketsWant to see more Cannabis Reform videos?🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLkWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
The Cannabis Industry Is Starting To Build Some Major Tailwinds | TTB Powered by Flowhub The Dales Report 2026-03-17 | Trade To Black Podcast hosted by Anthony Varrell is back with another must-watch episode covering the biggest developments in the cannabis industry, hemp regulation, CBD policy, multi-state operators, and global cannabis expansion.First, Anthony is joined by Eric Berlin of Dentons to discuss the recent FDA filing for CBD, what it could mean for the future of CBD regulation in the United States, and whether the market is moving toward a one-plant industry that brings cannabis and hemp together under a more unified framework. This conversation dives into the legal, regulatory, and commercial implications for operators, investors, and the future of the plant-touching economy.Next, Curaleaf CEO Boris Jordan joins the show to break down Curaleaf’s latest earnings, the company’s strategy for European growth, and his broader outlook on the cannabis industry. From international expansion and capital allocation to market positioning and sector headwinds, this is a key interview for anyone following Curaleaf stock, cannabis earnings, global cannabis markets, and MSO strategy.If you follow cannabis stocks, Curaleaf earnings, CBD regulation, hemp policy, FDA cannabis news, European cannabis growth, or the future of the cannabis and hemp industries, this episode of Trade To Black is one you do not want to miss.In today’s episode:FDA filing for CBDThe future of CBD regulationCannabis and hemp as a one-plant industryCuraleaf latest earningsBoris Jordan on European cannabis growthMSO strategy and cannabis industry outlookSubscribe to Trade To Black with Anthony Varrell for the latest interviews, cannabis news, hemp policy updates, earnings breakdowns, and analysis of the biggest stories shaping the legal cannabis industry.00:00:00 Intro, FDA CBD News & Newsom Clip00:02:51 Eric Berlin Intro & One-Plant Op-Ed00:03:46 Long-Term Vision for Cannabis Policy00:07:47 Hemp vs State-Legal Cannabis Tensions00:14:35 Building Cohesion & Industry Consensus00:19:26 Coalition Next Steps & Political Reality00:23:59 Transition & Sponsor Message00:25:31 Boris Jordan Intro & Curaleaf Turnaround00:27:09 Genetics, Dark Heart & Yield Gains00:31:34 Florida Strategy & Adult-Use Timing00:34:59 New York Market Update & Illicit Competition00:38:10 Exiting Hemp & Future for Beverages00:42:09 $500M Bond Deal & New Investors00:45:28 Europe Strategy & Margin Focus00:48:57 Germany & UK Market Potential00:54:00 Spain, France, Italy, Turkey & APAC00:56:26 US Expansion, Rescheduling & M&A01:01:13 2026 Outlook: Growth & Margins01:02:19 Wrap-Up & TDR+ Plug#TradeToBlack #AnthonyVarrell #Curaleaf #BorisJordan #EricBerlin #Dentons #CBD #FDA #CannabisNews #CannabisStocks #HempIndustry #MSO #EuropeanCannabis #CannabisInvestingWant to see more Cannabis Reform videos?🎬 youtu.be/Ty8MKF1z_Go🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLkWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Texas Hemp Market Faces Major Regulatory Change | TDR Cannabis in 5 The Dales Report 2026-03-17 | On the latest TDR Cannabis in Five powered by Frepouch.com, host Shadd Dales breaks down a major regulatory development coming out of Texas that could change one of the largest hemp markets in the United States in a big way.Texas regulators have finalized a rule that will force smokable hemp THC products off retail shelves by March 31, 2026. The rule was adopted by the Texas Department of State Health Services following a public hearing process that generated more than 1,400 public comments.Beginning next year, retailers in Texas will no longer be allowed to sell products such as THCA flower, pre-rolls, live resin, rosin, or other smokable hemp THC products.The change stems from Texas adopting a “total THC” calculation, which counts THCA toward the legal THC limit. Once THCA is included in that formula, most smokable hemp products exceed the allowable threshold, effectively removing them from the legal market.Edible hemp products such as gummies and THC beverages will still be allowed, but they will now face stricter testing, packaging, and licensing requirements.Texas has been estimated to represent a multi-billion-dollar hemp market, with a significant portion of that revenue coming from smokable products, particularly THCA flower.For operators, investors, and policymakers, the move could signal how other states may approach the intoxicating hemp loophole moving forward.00:00:00 Texas Hemp Update00:00:35 Smokable Hemp Ban00:01:12 Affected Products Explained00:01:56 Lawmakers Push Background00:02:34 Rule Finalized Enforcement00:03:11 Business Deadline Urgency00:03:47 Public Health Concerns00:04:25 Cannabis Hemp Distinction00:05:04 Intoxicating Hemp Confusion00:05:45 Smokable Product Focus00:06:20 Industry Impact Summary#CannabisNews #HempIndustry #TexasHemp #CannabisPolicy #THCA #CannabisRegulation #CannabisIndustry #CannabisInFive #ShaddDalesWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Viriginia Is For Cannabis Lovers and TerrAscend Earnings Download | TTB Powered by Flowhub The Dales Report 2026-03-16 | - Trade To Black Podcast with Anthony Varrell is back with another packed episode covering the biggest stories shaping the cannabis industry, multi-state operators, and hemp regulation.We kicks things off with Michael Bronstein of ATACH to break down the latest on Virginia cannabis, the evolving regulatory backdrop, and the implications of the pending Texas THCA flower ban. As lawmakers and regulators continue to crack down on intoxicating hemp and THCA products, this conversation dives into what it could mean for operators, consumers, and the broader cannabis and hemp markets.In our second segment both Ziad Ghanem and Jason Wild from TerrAscend (TSX: TSND) hop on to discuss the company’s latest earnings, operational performance, strategic priorities, and what investors should be watching next. From margin trends to market expansion and capital allocation, this segment offers a closer look at one of the industry’s most closely followed operators.If you follow cannabis stocks, MSOs, hemp regulation, THCA, Texas cannabis policy, Virginia cannabis news, or TerrAscend earnings, this is an episode you do not want to miss.Topics covered in today’s episode:- Virginia cannabis outlook- Texas THCA flower ban- Hemp-derived cannabinoid regulation- TerrAscend earnings breakdown- Cannabis investing trends- MSO strategy and market outlookSubscribe to Trade To Black for daily coverage of cannabis news, cannabis stocks, policy, earnings, and the biggest interviews in the industry.00:00 Intro: Trade To Black, weak MSO tape & “morally acceptable” cannabis poll02:33 Pennsylvania SB 49: Cannabis Control Board, hemp intoxicants & political math07:30 Gov. Shapiro, PA budget gap & adult-use legalization path11:45 Virginia goes adult use: pressure on Pennsylvania & East Coast map15:56 Texas 3/31 THCA flower ban: fallout for hemp, retailers & lawsuits20:23 Other state moves: Georgia expansion talk, NJ beverages & Farm Bill watch23:27 TerrAscend earnings: 2025 recap, margins, free cash flow & debt to 202827:22 Share buybacks & turning industry headwinds into tailwinds30:00 Core markets: New Jersey, Maryland and Pennsylvania outperformance35:00 Growth plan: deeper in Ohio & PA, selective M&A, why not New York (yet)41:37 Ohio & hemp strategy: adult-use delays, disciplined deals & skipping “hemp 1.0”46:04 PA adult use & Schedule III: timing bets, new grow rooms and federal outlook#TradeToBlack #AnthonyVarrell #CannabisNews #CannabisStocks #TerrAscend #THCA #TexasCannabis #VirginiaCannabis #HempNews #MSO #JasonWild #ZiadGhanemWant to see last week's recap?🎬 youtu.be/E6RoIpZ1zEYWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
MariMed Earnings Show Growth Amid Industry Challenges | Trade to Black The Dales Report 2026-03-16 | On the latest Trade To Black with host Shadd Dales, earnings season continues across the cannabis industry as more operators release their latest financial results.This episode takes a closer look at MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) following the company’s latest earnings report. MariMed reported $159.8 million in revenue for 2025 and marked its sixth consecutive year of positive adjusted EBITDA, something not many companies in the sector have managed during a period of continued pricing pressure across the industry.CEO Jon Levine and CFO Mario Pinho check in to walk through the company’s performance and discuss what’s driving the results.The conversation touches on the role of brand development within the cannabis sector, including the continued growth of MariMed’s Betty’s Eddies product line, along with the company’s wholesale distribution network, which now reaches roughly 85% of dispensaries across the markets where it operates.The discussion also turns to broader industry themes, including price compression, market competition, and how potential federal cannabis rescheduling could influence operators across the sector.00:00:00 MariMed Earnings Overview00:00:36 CEO and CFO Introduction00:01:50 Growth Despite Industry Challenges00:02:21 Brand Power Driving Growth00:03:50 Wholesale Channel Expansion00:04:32 Key Markets Focus00:05:23 Brand Equity Importance00:07:03 Cannabis Reform Discussion00:07:48 Wholesale vs Retail Strategy00:08:37 Margin Pressure Response00:10:36 Growth Investment Balance00:11:34 Expansion Strategy00:12:49 New York Market Outlook00:13:27 Debt Restructuring Impact00:14:16 Delaware Adult-Use Market00:16:55 Ohio Dispensary Plans00:18:29 CPG Platform Strategy00:20:08 Capital Efficient Partnerships00:21:28 Growth Opportunities Ahead00:22:07 M&A Strategy Outlook00:23:17 Brand Success Insights00:24:00 Investor Metrics Focus00:25:58 Rescheduling Impact00:27:16 2026 Industry Outlook00:28:05 TDR Plus Promotion#CannabisStocks #MariMed #CannabisEarnings #CannabisIndustry #CannabisInvesting #TradeToBlack #CannabisNews #MSO #CannabisMarket #ShaddDalesWant to see last week's recap?🎬 youtu.be/E6RoIpZ1zEYWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Cannabis vs Politics: The Inevitable The Dales Report 2026-03-16 | #Politics #Power #AI #Longevity #HumanNature #RealityCheck #Cannabis#LegalizeIt#FederalLegalization#ScheduleIII#CannabisReform#THCLimits#MarijuanaPolicy#CannabisIndustry#CannabisNews#DrugPolicyReform#RegulateCannabis#CannabisBusiness#WeedPolitics#EndProhibition
Big Week Across Cannabis Policy Courts and Earnings | TTB Weekly Recap The Dales Report 2026-03-15 | On the latest TDR Weekly Recap powered by frepouch.com, host Shadd Dales breaks down the biggest cannabis industry developments from the past week — spanning the courts, state legislatures, corporate earnings, and new scientific research.One of the most closely watched developments involves growing legal challenges moving through the U.S. court system that could eventually impact the federal Schedule I classification of cannabis and even Section 280E tax treatment for the industry. Recent arguments in U.S. v. Hemani before the U.S. Supreme Court highlighted how evolving federal policy around cannabis may begin to collide with long-standing legal restrictions.At the state level, Colorado lawmakers advanced Ryan’s Law, legislation that would allow terminally ill medical cannabis patients to use their medicine inside hospitals. Meanwhile, lawmakers in Tennessee reopened the debate around medical marijuana following President Donald Trump’s executive order directing federal cannabis rescheduling.On the corporate side, several major operators reported earnings this week, including Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), MariMed Inc. (CSE: MRMD) (OTCQX: MRMD), Village Farms International (NASDAQ: VFF) (TSX: VFF), and SNDL Inc. (NASDAQ: SNDL).The episode also covers new research from Hebrew University of Jerusalem suggesting cannabinoids such as CBD and CBG may help treat metabolic dysfunction-associated steatotic liver disease.From courtrooms to company balance sheets, the cannabis industry continues evolving as federal reform discussions move forward in Washington.00:00:00 TDR Weekly Recap Intro00:00:25 Federal Court Cannabis Challenge00:00:34 Colorado Ryan’s Law00:00:41 Tennessee Medical Cannabis Debate00:00:49 Cannabis Earnings Overview00:01:52 Court Challenges Explained00:04:40 Colorado Passes Ryan’s Law00:05:29 Tennessee Medical Marijuana Debate00:06:07 Verano Earnings Report00:06:39 MariMed Earnings Report00:07:10 Village Farms Earnings00:07:18 SNDL Earnings Breakdown00:08:04 CBD & CBG for MASLD Study00:09:00 Wrap-up & Upcoming guests#CannabisNews #CannabisIndustry #CannabisPolicy #CannabisReform #CannabisStocks #CannabisMarket #MedicalCannabis #CannabisResearch #TradeToBlack #TDRWeeklyRecapWant to see more Cannabis Reform videos?🎬 youtu.be/g07LnvPGc28🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLkWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Florida Adult-Use Cannabis Delayed | TDR Cannabis in 5 The Dales Report 2026-03-14 | On the latest TDR Trade To Black powered by frepouch.com, host Shadd Dales breaks down a major development coming out of Florida that many in the cannabis industry were watching closely.According to reporting first published by Marijuana Moment, the Florida Supreme Court has rejected an appeal from the Smart & Safe Florida campaign, effectively ending the effort to place adult-use cannabis legalization on the state’s 2026 ballot.The campaign needed roughly 880,000 valid signatures to qualify for the ballot but ultimately fell short after tens of thousands of petitions were invalidated by state officials. The court also stated that it would not entertain a rehearing, meaning the path for a 2026 vote is now officially closed.While the headline may appear negative at first, the broader reality is more nuanced. Florida remains one of the most important cannabis markets in the United States—even without adult-use legalization.The state’s medical cannabis program is already estimated to generate roughly $2 billion annually, with continued growth as the patient base expands. Major multi-state operators including Trulieve Cannabis Corp. (OTCQX:TCNNF), Curaleaf Holdings, (TSX:CURA), and Verano Holdings (CBOE: VRNO)(OTCQX: VRNOF) all have major exposure to the state through its medical market.With Governor Ron DeSantis term-limited and unable to run again, many observers now believe 2028 may represent the next realistic window for Florida voters to revisit adult-use legalization.For now, Florida remains one of the most strategically important cannabis markets in North America.00:00:00 Florida Adult-Use Update00:00:25 Adult-Use Not on 2026 Ballot00:01:16 Florida Supreme Court Decision00:01:43 Petition Signatures Shortfall00:02:09 Adult-Use Vote Blocked00:02:34 Why the Initiative Failed00:02:59 DeSantis Political Influence00:03:25 Importance of Florida Market00:03:51 Florida Cannabis Market Scale00:04:16 Medical Market Strength00:04:41 Industry Growth Outlook00:05:06 Long-Term Legalization Path00:05:31 Closing Thoughts#CannabisNews #FloridaCannabis #CannabisPolicy #CannabisIndustry #CannabisReform #CannabisStocks #CannabisMarket #MedicalCannabis #TradeToBlack #CannabisInFiveWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
The Future of Cannabis Delivery The Dales Report 2026-03-14 | #cannabis #cannabiscommunity #cannabisculture #marijuana #weed #thc #cbd
LEEF Brands (CSE: LEEF) Secures $4.5M Financing | Trade to Black The Dales Report 2026-03-13 | On the latest TDR Trade To Black podcast, hosts Shadd Dales and Anthony Varrell sit down with Micah Anderson, CEO of LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF), to discuss the company’s latest financing milestone and what it could mean moving forward.LEEF Brands Inc. announced earlier this week that its completed the first $4.5 million tranche of what could become an $8 million financing, with the majority of the capital directed toward expanding its core cultivation asset in California — the Solsbury Canyon Ranch in Santa Barbara County.During the conversation, Anderson explains how the new capital will help accelerate development of the ranch, which spans roughly 1,900 acres with 65 acres currently under cultivation through an existing land-use permit. The company’s strategy is to expand cultivation capacity while bringing more biomass supply in-house rather than relying as heavily on third-party suppliers.The discussion also touches on the realities of the California cannabis market, including the growing competition for clean cannabis biomass that can pass strict testing standards for pesticides and contaminants — a major issue for companies producing cannabis concentrates.Anderson also explains why Salisbury Canyon Ranch was strategically chosen for its geographic isolation, helping protect crops from pesticide drift that can affect cannabis farms located near traditional agricultural operations.The conversation also covers capital structure, expansion plans, and what investors should watch as LEEF Brands Inc. continues building out its California supply chain.00:00:00 Isolated Cannabis Ranch00:00:17 Leaf Brands Financing News00:00:41 Financing Impact Discussion00:00:58 CEO Interview Introduction00:01:32 $4.5M Funding Purpose00:02:13 Ranch Expansion Plans00:02:57 Financing Urgency Explained00:03:34 Investor Site Visit00:04:07 Second Tranche Timeline00:04:26 Biomass Supply Strategy00:05:08 Third-Party Supply Dependence00:05:27 California Biomass Prices00:06:04 Oil Price vs Biomass Trends00:06:30 Clean Cannabis Supply Issues00:07:23 Contaminant Concentration Problem00:08:03 Supply Chain Solution00:09:11 Future Medical Market Focus00:10:05 Importance of Clean Supply00:10:26 Competition for Clean Biomass00:11:06 Harvest Cycle Challenges00:11:40 Long-Term Supply Stability00:12:06 Financing Structure Details00:13:21 New Board Member Addition00:14:21 Investor Outreach Strategy00:15:02 Strategic Skill Gap on Board00:15:24 Growing Investor Interest00:16:03 Farm Investor Events00:16:37 Natural Pesticide Protection00:17:05 Ranch Location Advantage00:17:47 How the Ranch Was Found00:18:28 Key Investor Milestones00:19:25 California vs New York Focus00:19:41 CBD Program Possibility00:20:00 Wrap-up#CannabisNews #LEEFBrands #CannabisIndustry #CannabisInvesting #CaliforniaCannabis #CannabisStocks #CannabisBusiness #TradeToBlack #CannabisMarket #CannabisFarmingWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Cannabis Earnings Season: The Biggest Takeaways So Far | TTB Powered by Flowhub The Dales Report 2026-03-12 | On the latest Trade To Black podcast powered by Flowhub, hosts Shadd Dales and Anthony Varrell continue their coverage of cannabis earnings season with a closer look at some of the biggest results shaping the sector.In the first segment, George Archos, CEO of Verano Holdings (CBOE: VRNO | OTCQX: VRNOF), joins the show to break down the company’s latest earnings. Verano reported $821.5 million in 2025 revenue, while maintaining gross margins near 50% and adjusted EBITDA around 28% despite continued price compression across the cannabis industry. In the second segment, Adam Stettner, CEO of FundCanna, joins the podcast to discuss the biggest takeaways from this latest earnings season and what they mean for the cannabis industry moving forward. The conversation also touches on broader trends seen from recent reports by Green Thumb Industries (CSE: GTII | OTCQX: GTBIF), Trulieve Cannabis (CSE: TRUL | OTCQX: TCNNF), Curaleaf Holdings (TSX: CURA | OTCQX: CURLF) and others, including margin discipline, capital preservation, efficiency, and the growing importance of scale, cash flow, and balance sheet strength in today’s market.0:00 Intro: Cannabis earnings season & Flowhub sponsor1:30 Verano earnings breakdown: revenue, margins & key wins4:10 How Verano protected margins amid price compression6:05 Texas & Virginia: New growth markets and strategy9:40 Florida update: medical strength despite adult‑use setback12:10 Senior exchange status, uplisting path & reform outlook15:30 Verano refinancing: new debt terms, cost of capital & flexibility19:10 2026 vision: “Back to basics” and becoming a juggernaut22:00 Host recap: Why Verano trades at a discount to peers24:20 New segment: Adam Stettner (FundCanna) on sector health25:10 Big picture: What this earnings season really shows28:00 Price compression vs strong margins: maturity of MSOs31:00 Balance sheet discipline, refis & why the “maturity cliff” fizzled35:00 How strong MSOs support mid‑tier and small operators40:00 Why cash flow pure revenue growth in this phase47:00 Looking ahead: banking, new markets, and what could unlock the stocks49:30 Wrap‑up & preview of next week’s big guest lineup#CannabisStocks #CannabisInvesting #Verano #VRNOF #TradeToBlack #CannabisEarnings #MSOS #GreenThumb #Trulieve #CuraleafWant to see more Cannabis Reform videos?🎬 youtu.be/d83lBEf5y8E🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Trump Reportedly Exploring Cannabis Descheduling | TDR Cannabis in 5 The Dales Report 2026-03-12 | On the latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down a report that could signal a major shift in the federal cannabis conversation in Washington.According to reporting first published by The Marijuana Herald, Donald Trump is expected to sign an executive order later this year creating a federal commission tasked with studying the full descheduling of cannabis.If such a commission were formed, it would examine the legal, economic, regulatory, and public-safety implications of removing marijuana entirely from the Controlled Substances Act. That would go beyond the current federal rescheduling process, which aims to move cannabis from Schedule I to Schedule III.For the cannabis industry, the distinction is significant. Rescheduling could bring major changes such as relief from IRS rule 280E and expanded medical research opportunities. Descheduling, however, would represent a far larger shift by removing cannabis from the federal drug scheduling system altogether.According to the report, the proposed commission would include roughly a dozen members and would deliver a formal policy recommendation to the White House and Congress within about six months of being established.While the proposal would not immediately change federal law, it suggests the conversation in Washington may be beginning to expand beyond rescheduling and toward a broader debate over the long-term future of federal cannabis prohibition.00:00:00 Descheduling Rumors00:00:54 Breaking Down Descheduling00:01:20 Federal Recognition Impact00:01:46 Possible Policy Expansion00:02:13 Marijuana Legal Implications00:02:40 Presidential Executive Order00:03:07 Stepping Back Analysis00:03:33 Controlled Substances Act00:04:00 Federally Regulated Market00:04:54 Rescheduling First00:05:20 Industry Reactions#CannabisNews #CannabisReform #CannabisPolicy #CannabisDescheduling #CannabisIndustry #CannabisInvesting #FederalCannabis #CannabisStocks #TDRCannabisInFive #TradeToBlackWant to see more Cannabis Reform videos?🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoUWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Learn From Legal States The Dales Report 2026-03-12 | #CannabisPolicy #MedicalCannabis #CannabisLegalization #CannabisReform #CannabisIndustry #CannabisEducation #LegalizeCannabis #DrugPolicy #CannabisNews
Trump Could Consider Cannabis Descheduling | TTB Powered by Flowhub The Dales Report 2026-03-11 | On the latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell discuss a report that is beginning to circulate across the cannabis policy landscape in Washington. Reporting from The Marijuana Herald editor-in-chief Anthony Martinelli suggests that Donald Trump could potentially sign an executive order this summer tied to cannabis descheduling in the United States.To help break down what this could mean for the industry, Trade To Black brings back one of the most talked-about guests on the show — former hedge fund manager and longtime cannabis investor Marc Cohodes. Cohodes shares his reaction to the report and give his take on how the market could respond if Washington were to move beyond rescheduling and toward full federal descheduling.The industry has spent years debating rescheduling under the Controlled Substances Act, but the idea of removing cannabis entirely from the federal schedule would represent a much larger policy shift.If Washington ever seriously moved in that direction, the implications would be significant — not just for investors, but for operators, regulators, and the broader cannabis industry across the United States.00:00 Trump, cannabis, and the big question: reschedule or deschedule?01:28 Texas bans THCA flower & smokable hemp: warning shot from the states04:00 Mark Cohodes joins: “You need to embrace chaos”04:55 Is Trump really going to deschedule? Executive order chatter10:03 “Rescheduling with an asterisk”: banking, uplisting, and states’ rights16:26 How descheduling could crush cartels and the illicit market19:20 Election-year politics: why this move polls so well for Trump22:28 Why 4/20 and date-based predictions are a distraction#CannabisNews #CannabisReform #CannabisPolicy #CannabisDescheduling #MarcCohodes #CannabisInvesting #CannabisIndustry #CannabisStocks #FederalCannabis #tradetoblack Want to see more Cannabis Reform videos?🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoUWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Hemp And Marijuana Industries Leaders Potentially Aligning? | TTB Powered by Flowhub The Dales Report 2026-03-10 | On our latest Trade To Black podcast presented by Flowhub, hosts Shadd Dales and Anthony Varrell break down several stories currently making headlines across the cannabis industry.We begin in Florida, where the state Supreme Court rejected an appeal from marijuana legalization advocates attempting to restore invalidated ballot signatures. The decision effectively ends the campaign’s effort to place adult-use cannabis legalization on the 2026 ballot, closing the door — at least for now — on what many believed could have been one of the largest potential cannabis markets in the United States.We also look at new reporting suggesting that leaders from the hemp and marijuana industries may be finding some common ground on federal policy priorities. With cannabis rescheduling still under review in Washington and Farm Bill negotiations continuing in Congress, some stakeholders believe a more unified industry position could influence how cannabinoids are regulated moving forward.In addition, we discuss new research out of the Hebrew University of Jerusalem examining how cannabinoids like CBD and CBG may impact metabolic dysfunction-associated steatotic liver disease, known as MASLD. Early findings suggest these compounds could help reduce liver fat and improve metabolic function.Finally, Omar Khan, Chief Communications Officer at High Tide Inc. (NASDAQ: HITI | TSXV: HITI), joins the show to discuss the company’s decision to become a founding member of the National Compassionate Care Council and what that initiative aims to accomplish as federal cannabis policy discussions continue.00:00:00 Intro, market check & today’s lineup (High Tide, NCCC, Florida, liver study)00:04:21 Who is High Tide’s Omar Khan & why NCCC matters for US medical cannabis00:07:25 What is the NCCC? Goals, members & how it could shape US policy00:13:03 Where the real opportunity is: medical vs adult-use (US & Europe)00:19:39 Who will actually control US medical cannabis policy? Feds vs states vs industry00:23:40 Florida adult-use setback: why the Florida thesis is still intact00:28:19 Hemp vs marijuana: federal policy fight & industry alignment debate00:32:26 New Israeli research: CBD/CBG, fatty liver disease & the future of cannabinoid medicine#CannabisNews #CannabisPolicy #HighTide, #FloridaCannabis #CBDResearch #CBG #MedicalMarijuana #CannabisIndustry #CannabisReform #TradeToBlackWant to see more Cannabis Reform videos?🎬 youtu.be/Ug3xNK8loNA🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoUWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Georgia Lawmakers Push Cannabis Rescheduling | TDR Cannabis in 5 The Dales Report 2026-03-10 | A new development out of Georgia is adding another voice to the growing national conversation around federal cannabis reform.In this episode of TDR Cannabis in Five presented by frepouch.com, host Shadd Dales breaks down a new resolution introduced by Georgia lawmakers urging the federal government to move marijuana from Schedule I to Schedule III under federal law. The story was first reported by The Marijuana Herald and highlights how momentum around cannabis policy reform continues to expand across the United States.House Resolution 1524 calls on Washington to complete the ongoing federal rescheduling process under the Controlled Substances Act. While the resolution itself does not change federal law, it sends a clear political signal that state lawmakers want the federal government to align national drug policy with the medical cannabis programs already operating across much of the country.If cannabis were ultimately moved to Schedule III, the implications for the industry could be significant. One of the biggest changes would involve the potential removal of the IRS 280E tax burden that currently prevents cannabis companies from deducting normal business expenses.Rescheduling could also expand research opportunities and increase federal recognition of cannabis as a medicine.While the final decision still rests with federal regulators, actions like this from state legislatures show how the pressure for reform continues to build across the country.00:00 Introduction00:12 Georgia Cannabis Resolution00:58 Schedule I to Schedule III Push01:36 Federal Rescheduling Pressure02:01 2023 Federal Review Context02:33 DEA Rescheduling Debate03:09 Political Momentum Building03:42 Why Schedule III Matters04:18 Economic & Research Impact04:55 Georgia Lawmakers in Federal Reform05:29 Broader Cannabis Policy Shift06:02 Closing Thoughts#CannabisRescheduling #CannabisPolicy #ScheduleIII #CannabisIndustry #CannabisNews #GeorgiaCannabis #FederalCannabis #CannabisReform #280E #TDRCannabisWant to see more Cannabis Reform videos?🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Is Cannabis Rescheduling About To Happen This Week? | TTB Powered by Flowhub The Dales Report 2026-03-09 | Cannabis rescheduling is once again the dominant conversation across the industry. On this episode of Trade To Black powered by Flowhub, macro investor Doug Kass said Friday that a federal cannabis rescheduling announcement could be imminent, raising the question many investors are asking: could a decision finally arrive this week?Hosts Shadd Dales and Anthony Varrell break down the latest developments surrounding federal rescheduling and discuss what a potential announcement could mean for cannabis equities, investor sentiment, and the broader industry outlook.The show also features Anthony Coniglio, CEO of NewLake Capital Partners (OTCQX: NLCP), who joins the podcast to discuss the company’s latest earnings results. NewLake reported $12.3 million in quarterly revenue, beating expectations while continuing to generate stable cash flow in a challenging capital markets environment. Coniglio provides insight into tenant performance, capital allocation, and the outlook for cannabis real estate financing.Later in the episode, Michael Bronstein of the American Trade Association for Cannabis and Hemp (ATACH) joins the show to recap last week’s Farm Bill meetings in Washington. Notably, lawmakers did not discuss a delay to the proposed intoxicating hemp ban, which means the industry could still be on track for a nationwide ban on intoxicating hemp products by November 2026.Bronstein also explains new language being drafted around hemp definitions and what the evolving regulatory framework could mean for hemp and cannabis businesses moving forward. 00:00 Intro, Weekend Recap & Show Setup06:59 Guest: Anthony Coniglio (NLCP) on Twitter Sentiment & Rescheduling08:44 NLCP Earnings: Revenue, FFO & Dividend Strategy Explained09:46 Vacancies, Re‑Tenanting & Risk in Cannabis Real Estate15:00 Uplisting, REIT Valuations & Institutional Capital Potential19:15 Deal Pipeline, New State Opportunities & Hemp‑Derived THC Impact032:41 Insider’s Edge: Michael Bronstein on Farm Bill & Hemp “Ban” Fears35:23 Hemp Breakdown: Industrial vs Synthetic THC & THCA Flower40:00 Why Congress Says “Go to Energy & Commerce” for Final Product Rules45:00 Hemp Strategy: Regulation vs Delay and Who Survives Real Rules01:05:18 Outlook: Rescheduling, Federal Programs & Show Wrap‑Up#CannabisNews #CannabisRescheduling #CannabisStocks#MSOS #CannabisIndustry #NewLakeCapital #HempPolicy#FarmBill #CannabisInvesting #TradeToBlackWant to see last week's recap?🎬 youtu.be/S44kMdbs7fsWant to see more Cannabis Reform videos?🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Cannabis Rescheduling Pressure Builds in Washington | TTB Weekly Recap The Dales Report 2026-03-08 | It was another busy week across the cannabis industry, with developments spanning policy, corporate earnings, and scientific research. In this episode of TDR Weekly Recap presented by frepouch.com, host Shadd Dales breaks down the most important stories shaping the sector right now.The week began with a major legal development at the U.S. Supreme Court, where justices heard oral arguments in U.S. vs. Hemani, the case challenging the federal prohibition on firearm ownership for cannabis users under Section 922(g)(3). Several justices appeared skeptical of the government’s position, especially as federal cannabis policy continues to evolve.At the same time, speculation around federal rescheduling intensified following fresh reporting out of Washington involving Attorney General Pam Bondi and the pace of the process.On the business side, earnings season continued with NewLake Capital Partners (OTCQX: NLCP) and Cresco Labs (CSE: CL) (OTCQX: CRLBF) both reporting results. NewLake once again highlighted balance sheet strength and steady dividends, while Cresco posted improving margins and stronger cash generation despite non-cash impairment charges.Additional corporate headlines included product innovation from Organigram Holdings (NASDAQ: OGI) (TSX: OGI), retail expansion in Ohio from Vext Science (CSE: VEXT) (OTCQX: VEXTF), and board changes at High Tide (NASDAQ: HITI) (TSXV: HITI) as the company continues expanding globally.With rescheduling, Farm Bill negotiations, and earnings all moving at once, the cannabis sector remains in a critical stretch.00:00:00 – Intro00:00:43 – US Supreme Court: Gun Rights & Cannabis00:02:55 – Federal US Rescheduling Rumors00:04:33 – 2026 Farm Bill Update00:06:02 – NewLake Capital Q4 Financial Result00:07:41 – Cresco FY2025 Earnings00:08:20 – Cresco Q42025 Earnings00:08:38 – Megan McCain on Cannabis00:09:41 – Oxford Population Health Cannabis Study00:10:24 – OGI Launches SHRED Shotz00:10:36 – Vext Science Expands in Ohio00:10:47 – High Tide Board Refresh00:10:59 – Wrap up#CannabisNews #CannabisIndustry #CannabisRescheduling #CannabisStocks #CannabisPolicy #CannabisEarnings #CannabisInvesting #CannabisResearch #CannabisWeekly #TDRWeeklyRecapWant to see more Cannabis Reform videos?🎬 youtu.be/ZUrEkYzueLk🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Would Bondi’s Removal Stop Rescheduling? | TDR Cannabis in 5 The Dales Report 2026-03-07 | Rumors circulating in Washington have raised a new question for the cannabis industry: what would happen to federal cannabis rescheduling if Pam Bondi were removed from office?In this episode of TDR Cannabis in Five powered by Flowhub, host Shadd Dales breaks down how the federal rescheduling process actually works and why a leadership change at the United States Department of Justice would not stop the rule from moving forward.Cannabis rescheduling is governed by the Controlled Substances Act and involves multiple federal institutions, including the Drug Enforcement Administration and the U.S. Department of Health and Human Services. Once the administrative rulemaking process is underway, it becomes institutional rather than dependent on any single political figure.Even if the Attorney General were replaced, the rule could still be signed and transmitted to the Office of the Federal Register by an acting attorney general.The discussion comes as speculation grows around potential federal cannabis reform under Donald Trump, alongside market commentary from investor Doug Kass, who recently highlighted the AdvisorShares Pure US Cannabis ETF as a trade idea amid expectations of a possible rescheduling announcement.While timing may still shift slightly depending on where the rule sits in the federal pipeline, the broader takeaway remains the same: cannabis rescheduling is driven by the rulemaking process itself, not by a single individual.00:00:00 – Intro00:00:31 – Rescheduling Delays00:01:01 – Leadership Questions00:01:33 – Rescheduling Process00:02:05 – DOJ Rule Discussion00:02:35 – Structural Changes00:03:06 – Timing Impact00:03:36 – Scenario Two00:04:07 – Policy Not Reversed00:04:38 – Trump Disappointed00:05:09 – Bondi Firing Rumors00:05:40 – Political Pressure00:06:11 – Cannabis Policy Stakes00:06:42 – Market Reaction00:07:13 – What Happens Next00:07:44 – Closing Thoughts#CannabisRescheduling #CannabisPolicy #ScheduleIII #CannabisIndustry #CannabisInvesting #CannabisNews #MSOS #CannabisReform #FederalCannabis #TDRCannabisWant to see more Cannabis Reform videos?🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yIWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Joe Rogan: Debunking Cannabis Stereotypes The Dales Report 2026-03-06 | #Cannabis#CannabisCommunity#CannabisCulture#WeedCommunity#CannabisEducation#CannabisMyths#MythBusting#CannabisFacts#DidYouKnow#CannabisScience#BreakTheStigma#EndTheStigma#KnowTheFacts
Congress Advances Farm Bill Without Hemp THC Delay | TDR Cannabis in 5 The Dales Report 2026-03-06 | Congress has advanced a new version of the U.S. Farm Bill that includes updated hemp provisions, but notably lawmakers did not include the delay hemp stakeholders were requesting for a federal THC ban. That decision could have major consequences for the fast-growing hemp-derived cannabinoid market.In this episode of TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down what just happened in Washington and why it matters for both the hemp industry and the broader cannabis sector.The issue traces back to the Agriculture Improvement Act of 2018, which legalized hemp federally by defining it as cannabis containing less than 0.3% delta-9 THC. While the law removed hemp from the Controlled Substances Act, it also created what many now refer to as the “hemp loophole.”Because the legislation focused only on delta-9 THC, companies were able to sell intoxicating hemp-derived cannabinoids such as delta-8 THC and high-THCA products. Over time, that loophole helped create a multi-billion-dollar hemp cannabinoid market sold across smoke shops, convenience stores and online retailers nationwide.Now lawmakers are moving to tighten those rules by shifting to a “total THC” standard, which would count all forms of THC rather than just delta-9.At the same time, Washington is moving closer to federal cannabis rescheduling under the Controlled Substances Act.With hemp regulation and marijuana policy reform unfolding simultaneously, the next phase of cannabis regulation in the United States could be shaped by how these two policy tracks intersect.00:00:00 – Intro00:00:20 – New Farm Bill 00:01:01 – Hemp Loophole Created 00:01:23 – Federal Law Conflict 00:02:07 – Proposed Hemp Restrictions 00:02:29 – Complex Policy Debate 00:04:35 – Industry Preparing Ahead 00:04:57 – Cannabis Rescheduling Context 00:05:18 – Impact On Hemp 00:05:39 – Industry Reaction 00:06:00 – What Happens Next #CannabisNews #FarmBill #HempIndustry #CannabisPolicy #THCBan #CannabisRegulation #CannabisReform #Delta8 #CannabisIndustry #TDRCannabisWant to see more Cannabis Reform videos?🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yIWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Whats Really Happening With Cannabis ETF MSOS? | TTB Powered by Flowhub The Dales Report 2026-03-05 | A lot of cannabis investors still haven’t fully recovered from the December 18 pullback. Since then, the sector has struggled to regain momentum and many traders watching the tape believe something unusual has been happening around the MSOS ETF, especially around option expiries and large flow days. Whether it’s heavy volume without price movement, short interest shifting between MSOS and MSOX, or cannabis stocks moving together across the board, the questions from investors keep piling up.Today on Trade To Black presented by Flowhub, host Shadd Dales is teeing up a big conversation with Dan Ahrens of AdvisorShares, the portfolio manager behind the AdvisorShares Pure US Cannabis ETF (MSOS). The interview goes live at 4 PM Eastern, and the goal is simple: get answers to the questions investors have been asking for months.Among the topics we’ll cover:• Are institutions quietly positioning in cannabis again?• Why does MSOS sometimes trade heavy volume with little price movement?• What role do short sellers and options activity play in the sector’s volatility?• How does the ETF creation process actually work?• And what would it take to stabilize cannabis markets going forward?With cannabis reform still looming and the market structure under the microscope, this conversation should give investors a clearer picture of what’s really happening behind the scenes.Like, subsribe and leave your comments!0:00:00 Intro & show setup (Trade to Black x Dan Ahrens)0:02:30 State of U.S. cannabis after Trump’s executive order0:05:10 Recent MSO earnings (Curaleaf, Trulieve, GTI, Cresco) vs stock action0:08:20 Rumors, timing uncertainty & why to ignore “next week” calls0:10:40 MSOS & YOLO performance vs S&P 500 over the past year0:14:00 Manipulation”, low liquidity & how OTC cannabis names trade0:19:30 How MSOS actually works: NAV, creations/redemptions, swaps0:25:40 MSOX, leverage, short interest & impact on MSOS0:31:30 What rescheduling needs: DOJ guidance, states’ rights & banking0:38:40 Up‑listing to NYSE/Nasdaq & when real institutional money arrives0:46:30 Portfolio construction: concentration in Curaleaf, GTI, Trulieve0:54:20 YOLO, leading names (VFF, High Tide, OGI, Charlotte’s Web) & outlook#CannabisStocks #MSOS #CannabisInvesting #AdvisorShares #CannabisMarket #CannabisETF #CannabisIndustry #CannabisReform #StockMarket #TradeToBlackWant to see more Cannabis Reform videos?🎬 youtu.be/E9cRyGGtHIE🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yIWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Why Rescheduling Alone Won’t Fix Cannabis | TDR Cannabis in 5 The Dales Report 2026-03-05 | A new op-ed published in Marijuana Moment is raising questions about the future of the U.S. cannabis industry. Written by Gennaro Luce and Matthew Myro Rothman, the piece argues that even if the federal government moves cannabis from Schedule I to Schedule III under the Controlled Substances Act, that change alone may not be enough to stabilize the industry long-term.In this episode of TDR Cannabis in Five, host Shadd Dales walks through the argument presented in the op-ed and explains why healthcare integration may ultimately determine the long-term success of the cannabis industry. While rescheduling could eliminate the tax burden created by Internal Revenue Code Section 280E—a major financial hurdle for cannabis companies—the authors argue that the real structural issue lies elsewhere.Unlike traditional pharmaceuticals, medical cannabis is rarely covered by insurance plans, meaning most patients must pay out of pocket. According to the authors, without insurance reimbursement and deeper integration into the healthcare system, cannabis could struggle to reach the same level of legitimacy and accessibility as conventional medicine.With federal rescheduling potentially on the horizon under the Donald Trump administration, the conversation about what comes next for cannabis policy is becoming increasingly important.The question now isn’t just whether cannabis will be rescheduled—it’s whether the healthcare system will eventually treat it like medicine.00:00:00 – Intro00:00:49 – Industry Stability Concerns00:01:28 – Insurance Market Opportunity00:02:21 – Federal Recognition Impact00:03:08 – Cannabis As Medicine00:03:57 – New Market Creation00:04:38 – Industry Structural Challenges00:05:29 – Future Policy Questions00:06:12 – Closing Thoughts#CannabisIndustry #CannabisRescheduling #ScheduleIII #CannabisPolicy #MedicalCannabis #CannabisReform #CannabisInvesting #CannabisHealthcare #CannabisNews #TDRCannabisWant to see more Cannabis Reform videos?🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yI🎬 youtu.be/gn2-FXjmtq8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
The Most Important Cannabis Stats of 2026 | TTB Powered by Flowhub The Dales Report 2026-03-04 | In the latest episode of Trade To Black presented by Flowhub, host Shadd Dales and Anthony Varrell break down the latest developments emerging from today’s Farm Bill hearing in Washington, where lawmakers are debating how hemp and cannabis policy could be redefined moving forward.There’s a lot riding on what happens in this bill on how hemp-derived cannabinoids will be regulated. Then we turn to Michigan, where the cannabis market is dealing with growing political pushback. Eight bipartisan state senators are now moving to repeal the state’s newly implemented 24% cannabis wholesale tax, which was layered on top of the existing excise and sales taxes. Adam Stettner, CEO of FundCanna joins us to outline that tax was projected to generate roughly $421 million annually, but early numbers suggest operators are already feeling the pressure.January dispensary sales fell 8.3% year-over-year, even as product volume reached record highs — a clear sign that operators are selling more cannabis for less money in one of the most competitive markets in the country.In segment two, Flowhub CEO Kyle Sherman joins the podcast to highlight some key industry statistics, including the fact that 47% of Americans have tried cannabis, adult-use cannabis is now legal in 24 states, and the U.S. cannabis industry is expected to reach nearly $47 billion in 2026.Like, subscribe and leave your comments!00:00:00 Intro: MSOS Price Action & Cannabis Rescheduling Talk00:05:12 Michigan Cannabis Market: Introducing FundCanna CEO Adam Stettner00:07:25 Michigan’s 24% Cannabis Wholesale Tax: Why Repeal Is on the Table00:09:10 40% Effective Cannabis Tax in Michigan: Price Compression & Black Market00:15:33 How to Fix Michigan Cannabis Oversupply & Unlimited Licenses00:18:40 How Lenders Underwrite Risk in Michigan’s Cannabis Market00:26:12 Michigan Cannabis Sales: ~$3B Market, Border Shoppers & Ohio Impact00:29:40 12–18 Month Outlook: Michigan Cannabis, Schedule III & SAFE Banking00:34:26 U.S. Cannabis Industry Forecast: Up to $47B Revenue by 202600:36:11 Cannabis Operators’ Reality: Profitability, Consolidation & Exhaustion00:45:00 Cannabis E‑Commerce & Delivery: Regulations vs Profitability#CannabisIndustry, #FarmBill, #CannabisPolicy, #MichiganCannabis, #CannabisTaxes, #CannabisEconomy, #CannabisBusiness, #CannabisMarket, #CannabisNews, #CannabisInvestingWant to see more Cannabis Reform videos?🎬 youtu.be/oauQIR_gJoU🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yI🎬 youtu.be/gn2-FXjmtq8Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Massachusetts Voters Reject Cannabis Rollback | TDR Cannabis in 5 The Dales Report 2026-03-04 | Welcome back to TDR Cannabis in Five delivered by FrePouch.com with host Shadd Dales.Massachusetts has been raising eyebrows in recent months after a proposal surfaced that would effectively roll back legal marijuana sales in the state. But the latest polling data suggests the outcome may already be clear: voters overwhelmingly oppose the idea of reversing legalization.A new statewide poll shows roughly two-thirds of Massachusetts voters oppose the ballot initiative that would repeal legal cannabis sales, while only about 20 percent support it. The numbers reinforce what many in the cannabis industry have argued for years — once regulated markets are established, public appetite for reversal tends to disappear.Massachusetts legalized adult-use cannabis in 2016, and since then the market has generated billions in legal sales, hundreds of millions in tax revenue, and thousands of jobs across the state.The controversy surrounding the proposal has also intensified after surveys suggested that many residents who signed the petition may not have realized the measure was aimed at repealing legal marijuana sales. Some respondents said the petition was framed around unrelated issues such as housing or public safety.Regardless of how the initiative reached this stage procedurally, the broader takeaway appears clear.Nearly a decade after legalization, Massachusetts voters show little interest in turning the clock back on the regulated cannabis market.00:00:00 Intro00:00:18 Massachusetts Legalization00:00:43 Voters Oppose Repeal00:01:06 Massachusetts Legalized Cannabis00:01:46 SAM Repeal Campaign00:02:00 Misled Petition Signers00:02:33 Regret Signing Petition00:03:01 Signature Gathering Controversy00:03:24 Voters Reject Reversal00:03:48 Repeal Politically Unlikely00:04:05 Cannabis Economic Impact00:04:56 Voters Support Legalization00:05:20 Legalization Support Growing00:05:39 Ballot Proposal Closing#MassachusettsCannabis #CannabisLegalization, #CannabisPolicy, #CannabisIndustry, #CannabisNews, #AdultUseCannabis, #CannabisMarket, #CannabisReform, #CannabisBusiness, #CannabisInvestingWant to see more Cannabis Reform videos?🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yI🎬 youtu.be/gn2-FXjmtq8🎬 youtu.be/9njbcEmjYbEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
SAM Admits Cannabis Has Medicinal Value The Dales Report 2026-03-04 | #MedicalCannabis#MedicalMarijuana#CannabisMedicine#CannabisHeals#CannabisCures#medicinalcannabis #CannabisIndustry#CannabisPolicy#CannabisLegalization#CannabisEducation#EndTheStigma
Cannabis Banking Grows As Reform Looms | TTB Powered by Flowhub The Dales Report 2026-03-03 | 00:In the latest episode of Trade To Black presented by Flowhub, host Shadd Dales and Anthony Varrell sit down with the CEO of Safe Harbor Financial (NASDAQ: SHFS) to break down the surge of cannabis banking in emerging markets over the past year. Safe Harbor reported a 29% year-over-year increase in average deposit balances across emerging U.S. markets. Those markets now account for 31% of total deposits. The growth came from more than 100 new customer accounts and expanding operators in states like New York, Ohio, Delaware, Minnesota and Florida.In the second segment, the conversation switches to the Supreme Court, where justices appeared skeptical of the federal government’s defense of banning marijuana users from owning firearms — especially as cannabis rescheduling potentially shifts to Schedule III.Plus, MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) restructured its balance sheet by extending maturities by more than four years, Also, Massachusetts voters pushing back strongly against efforts to repeal adult-use legalization, and new data showing nearly 10 million Americans microdosed psychedelics in 2025.Log on and leave your comments! Like and subscribe as well.00:00:00 Show open, market selloff & cannabis stocks green00:00:26 Supreme Court, DOJ stance & cannabis rescheduling discussion00:05:00 Sponsor – Flowhub cannabis retail platform00:05:34 Safe Harbor CEO Terry Mendez on NASDAQ listing & cannabis banking00:09:34 Emerging markets, deposit growth & lending flywheel strategy00:16:20 New York / Tri‑State boom, 420IT acquisition & East Coast expansion00:18:45 What Schedule III changes (and doesn’t) for cannabis banking00:21:56 Beyond real estate – New lending products & Safe Harbor rebrand00:25:19 Uplisting realities – NASDAQ requirements, reverse splits & public-company costs00:39:20 Segment 2 – MariMed debt restructuring & balance sheet runway00:40:00 Massachusetts legalization repeal effort & voter sentiment00:46:54 Psychedelics & the rise of microdosing in mainstream culture00:48:56 Michigan’s controversial wholesale tax & early impact on sales00:51:38 Beverage strategy, hemp drinks & alcohol’s role in THC beverages00:53:37 Wrap‑up & TDR Plus community promo#CannabisStocks, #SafeHarborFinancial, #SHFS, #MariMed, #MRMD, #CannabisBanking, #ScheduleIII, #CannabisRescheduling, #MassachusettsCannabis, #PsychedelicsWant to see more Cannabis Reform videos?🎬 youtu.be/Q6ByFdZ5XXQ🎬 youtu.be/Unu39i1C_yI🎬 youtu.be/gn2-FXjmtq8🎬 youtu.be/9njbcEmjYbEWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
Can Cannabis Rescheduling Happen During War? | TDR Cannabis in 5 The Dales Report 2026-03-03 | In this episode of TDR Cannabis in Five, host Shadd Dales breaks down a growing question in the cannabis industry: can federal cannabis rescheduling still move forward during a time of geopolitical conflict?With global tensions escalating, oil prices reacting, and concerns rising about inflation and supply chain risk, investors are reassessing market exposure across sectors. Naturally, that has led to speculation about whether cannabis reform — specifically the potential rescheduling of marijuana under the Controlled Substances Act — could be delayed.This episode explains the difference between political focus and legal authority. Cannabis rescheduling is an administrative process led by the Department of Justice and the DEA, based on scientific review from Health and Human Services. It does not require Congress and does not legally pause during wartime or international instability.Shadd outlines how past conflicts did not halt federal rulemaking, what matters procedurally in the rescheduling process, and how macroeconomic volatility could actually increase the importance of 280E tax relief for U.S. operators.For cannabis investors watching both Washington and global markets, this episode separates legal fact from market narrative — and explains what truly determines whether rescheduling hits the Federal Register.00:00:00 Intro & Market Setup00:00:05 Geopolitical Tensions & Market Reaction00:00:25 What Does This Mean for Cannabis?00:00:31 Does Overseas Conflict Impact Rescheduling?00:00:39 Three Immediate Macro Concerns00:01:06 Does War Freeze U.S. Rulemaking?00:01:12 How Cannabis Rescheduling Actually Works00:01:54 Historical Proof: Rulemaking Continues During War00:02:11 Could Political Focus Shift?00:02:31 What Cannabis Investors Should Focus On00:03:21 Economic Impact on the Cannabis Sector00:03:31 280E Tax Relief & Cash Flow Impact00:03:53 The Psychological Factor in Markets00:04:21 Can Pam Bondi Legally Sign Off During Conflict?00:04:39 Separating Narrative from Legal Reality00:04:55 The Timing & Political Will00:05:00 Closing Thoughts#CannabisRescheduling #ScheduleIII #CannabisStocks #280E #FederalReform #DEA #DOJ #CannabisInvesting #MacroMarkets #CannabisPolicy #IranWar #Israel Want to see more Cannabis Reform videos?🎬 youtu.be/Unu39i1C_yI🎬 youtu.be/gn2-FXjmtq8🎬 youtu.be/9njbcEmjYbE🎬 youtu.be/a3a62wgjKHsWant to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:newsletter.thedalesreport.com/subscribeFind us on social media and podcast platforms:✅ Facebook: facebook.com/TheDalesReport✅ Twitter: twitter.com/TheDalesReport✅ Instagram: instagram.com/dalesreport✅ LinkedIn: linkedin.com/company/the-dales-reportApple Podcasts: tinyurl.com/TDRTradetoBlackonApplePodcastsSpotify: tinyurl.com/TDRTradeToBlackonSpotifyWebsite: thedalesreport.comFor copyright matters, contact:sdales@thedalesreport.comPodcast Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: thedalesreport.com/website-terms-of-use
